chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1/12/22 68 yr/o  female past medical history of anemia hypertension multiple myeloma her hematologist is Dr., she is fully vaccinated and boosted against COVID  Has been feeling badly for a few days tested positive for COVID on January 10 2 days previously, woke up this morning feeling awfully weak tired short of breath and so called EMS    Her shortness of breath limits history  EMS reports finding her satting 70% on room air tachycardic but normotensive on their arrival, but time I evaluate patient she is on nasal cannula satting in low 90s but tachypneic to the 30s  She denies chest pain ROS   Gen: Negative except as in HPI Eyes: no redness and no drainage ENT: no rhinorrhea and no congestion  ROS   CV: no murmur and no chest pain Resp: Negative except as in HPI GI: no nausea , no vomiting and no diarrhea GU: good UOP MSK: no back pain, no joint swelling, no myalgias Neuro: no weakness, no numbness, no headache Hem: no bruising and no bleeding Skin: no rash  Admit date: 1/12/2022    Discharge date and time: 1/17/2022, 5:07 PM    Discharge Diagnoses: Principal Problem:   Acute respiratory failure due to COVID-19 (CMS/HCC) (1/12/2022)   Active Problems:   Multiple Myeloma of 2016 (7/25/2016)     Hyperlipidemia (9/25/2017)     Chronic pain (5/30/2020)    Followed by palliative care service (5/30/2020)     Multiple myeloma in relapse (CMS/HCC) (1/19/2021)    Cardiomyopathy (CMS/HCC) (1/14/2022)     LV dysfunction: EF=26% (1/17/2022)     Hypotension (arterial) (1/17/2022)    Discharge Condition: deceased   Consults:  INPATIENT CONSULT TO PHARMACY IP CONSULT TO HOSPITALIST IP CONSULT TO PULMONOLOGY IP CONSULT TO CARDIOLOGY IP CONSULT TO HEMATOLOGY IP CONSULT TO PALLIATIVE CARE INPATIENT CONSULT TO PHARMACY IP CONSULT TO PALLIATIVE CARE   Hospital Course:   Acute hypoxic Resp failure Covid + Vaccinated yet compromised status - Multiple Myeloma  CTA noted  Bipap-O2 support -> intubation and Vent today  pulm tx Steroids remdesivir Empiric abx's initiated  Now on baricitinib  Check procal  Ok  Tenuous status throughout  Monitored closely - inflam markers  pulm CC followed   Hypotension  Post intubation  Pressor support -IVF's- along with Amio ->ST Wean     New Onset Sys HF -CM Elevated Trop BNP + Echo EF 26% Cards eval-mgmt  Med rx  - IV diuresis    Cards initiated Isordil ,hydralaine,  note BB allergy    Lisinopril , aldactone  Hep gtt    AKI Rising Bun/Cr Setting of diuresis Concern with possible ATN - hypotension   Hyperglycemia  -sec steroids and TF's Added Basal  SS a1c -6.6 Trend    MM Followed by hematology Asked to see Cont same - add followed by Palliative care  - ask to see apprec input   HLD Was On statin    Nut - NPO DHT-TF   DVT ppx- AC   Code Status-DNR Clinical course worsened throughout the day As above - now intubated -Required multiple pressors - Pulmonary Critical Care spoke with family - now at bedside - along with Palliative service - > family opted to pursue terminal / compassionate extubation with comfort measures- with subsequent death
shingles outbreak; PHN; This case was reported by a consumer via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. In November 2019, less than a month after receiving Shingrix, the patient experienced post herpetic neuralgia. On an unknown date, the patient experienced shingles. On an unknown date, the outcome of the shingles and post herpetic neuralgia were unknown.   It was unknown if the reporter considered the shingles and post herpetic neuralgia to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. Six months ago from the date of the date of reporting the patient received Shingrix and had shingles outbreak and was treated for PHN in November 2019.
Information has been received from a physician concerning a 14 week old patient who on 26-JUL-2007 was vaccinated with ROTATEQ vaccine live (human-bovine) later than 13 weeks of age at another practice. It was reported that the patient's parents consulted with the physician. Current patient status was not reported. No product quality complaint was reported. No further information was available. Additional information has been requested.
This spontaneous report as received from an other health professional refers to a patient of unknown age and gender, with no concurrent conditions and medical history reported. On 02-AUG-2017, the patient was vaccinated with improperly stored (18 hours in temperature -12 Celsius degrees) PROQUAD lot # M041083, therapy type RHA, expiration date 04-APR-2018 (route of administration was not reported). Other suspect therapy included sterile diluent lot # K019027, expiration date 07-AUG-2017 (dose, frequency and route of administration were not reported). No adverse effects were reported. No adverse effects were reported. This is one of four reports from the same reporter. Sender's Comments: US-009507513-1708USA002682: US-009507513-1709USA000307: US-009507513-1709USA000306.
This spontaneous report as received from a licensed practical nurse refers to a 69 year old female patient. The patient had no pertinent medical history. The patient had experienced several drug reactions or allergies in the past. Doxycycline (unspecified dose, manufacturer and dates of administration) caused the patient to have diarrhea, stomach ache and headache. Famotidine (unspecified dose, manufacturer and dates of administration) caused the patient to feel sick (unspecified symptoms). Zoloft (unspecified dose and dates of administration), caused the patient to have increased anxiety, major heart burn and nightmares. LEXAPRO (unspecified dose and dates of administration) caused the patient to experience nausea, decreased appetite and heart palpitations. EFFEXOR (unspecified dose and dates of administration) caused the patient to experience nausea, burning in throat, weakness and headaches. BIAXIN (unspecified dose and dates of administration) caused an unspecified reaction. Approximately on an unknown date in 2004 (reported as 10 years ago), the patient was vaccinated with a dose of ZOSTAVAX, (lot number, expiry date and route was not reported). Concomitant medications were unknown. On 26-MAR-2013, the patient visited an eye doctor who found a shingles like rash located on patients eye brown. The patient was seen in the emergency room either between 29-MAR-2013 or 31-MAR-2013 due to unspecified reason related to shingles like rash. The patient was diagnosed with shingles and treated with acyclovir and was released on the same day. The outcome of the event was reported as not recovered. The patient sought medical attention. Additional information has been requested.
Massive ischemic stroke due to blood clot on right side of the brain, in a coma for 5 weeks then additional 6 weeks in minimally conscious state before fully awakening to permanent disability.  Primary disabilities include loss of hearing, memory/attention, partial loss of vision, and loss of ability to perform normal daily activities independently.  Treated in  Hospital for first 5 weeks of treatment, then several facilities
Small headache; Diarrhea for approximately 15 minutes both nights; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea for approximately 15 minutes both nights) and HEADACHE (Small headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced DIARRHOEA (Diarrhea for approximately 15 minutes both nights). On 27-Jan-2021, the patient experienced HEADACHE (Small headache). The patient was treated with PARACETAMOL (TYLENOL) on 27-Jan-2021 for Headache, at a dose of UNK dosage form. On 26-Jan-2021, DIARRHOEA (Diarrhea for approximately 15 minutes both nights) had resolved. At the time of the report, HEADACHE (Small headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
I felt extremely foggy headed. It was like I was struggling to put thoughts together at times. Also, it was like I was having trouble focusing on and off. The foggy headed last mainly the first day of vaccination, then some on the second day after.  This happened about 15 minutes after receiving the vaccine.  Also, exhausted feeling on and off the first night of vaccination.
Shortness of breath hard to breathe Pounding heart Inflammation in the heart muscle Elevated heart enzymes
Notes (Nurse Practitioner) ? ? Nurse Practitioner Cosigned by:  MD at 3/19/2021  9:22 AM Expand AllCollapse All      3/18/2021    Subjective female who was seen at Clinic today for her first  dose of the COVID 19 vaccination.    She was given the Pfizer vaccination in the left deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience lightheadedness and dizziness.  She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to abdominal pain, blood pressure abnormality , chest pain, collapse, drooling, hypotension, increased swelling, rapid progression of symptoms, respiratory distress, skin changes, tongue swelling and vomiting.   Pt became hot and light headed after receiving her shot.  She was brought by WC to the bay. She was given water and an ice pack was laid on the back of her neck.     ALLERGY REVIEW OF SYSTEMS:  Patient complains of dizziness    Hot and sweaty: CONT negative HENT negative Eyes negative Respiratory negative Skin negative GI negative Musculo negative     Previous Reactions: None    Objective    Vitals Vitals:   03/18/21 1535 03/18/21 1550 BP: 131/67 130/75 Pulse: 84 65 SpO2: 100% 100%          Physical Exam Vitals and nursing note reviewed.  Constitutional:      Appearance: She is well-developed.  HENT:     Head: Normocephalic and atraumatic.     Right Ear: External ear normal.     Left Ear: External ear normal.     Nose: Nose normal.  Eyes:     Conjunctiva/sclera: Conjunctivae normal.     Pupils: Pupils are equal, round, and reactive to light.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal.     Breath sounds: Normal breath sounds.  Abdominal:     General: Bowel sounds are normal.     Palpations: Abdomen is soft.  Musculoskeletal:        General: Normal range of motion.     Cervical back: Normal range of motion and neck supple.  Skin:    General: Skin is warm and dry.     Capillary Refill: Capillary refill takes less than 2 seconds.  Neurological:     Mental Status: She is alert and oriented to person, place, and time.        Assessment/Plan  Treatment included: water and ice pack Follow up response to treatment: excellent. Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Local reaction (arm pain, bleeding/bruising, mechanical irritation, localized rash) Pt dismissed to go home at 3:57pm with coworker.        Electronically Signed 3/18/2021 4:00 PM
Dr consult EMS called to assess via 911 Dr visit in person Urgent Care  Trouble breathing, dizziness, heart pain, numbness and tingling in extremities, blurred vision, muscle spasms, poor muscle tone, rapid heart rate, drop in blood pressure, elevated heart pressure, trouble talking, brain fog, intestinal upset, cold sweats, tremor, poor coordination, restlessness, fatigue  Onset at time of vaccine administration  Labeled NOT anaphylaxis
No additional adverse effect reported; a male Patient received improperly stored VAQTA (lot S009562 & expiration date 7/26/2020).; This spontaneous report was received from a medical assistant referring to a 3 years old male patient. Information about medical history, concurrent conditions and concomitant therapies was not provided.    On 05-NOV-2019, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated (VAQTA) vial 25/0.5(unit not provided) (lot # S009562, expiration date 26-JUL-2020; dose and route were not reported) for prophylaxis (product storage error). Temperature excursion was above 47 degrees Fahrenheit (52.09 degrees Fahrenheit) for 1.39 hours. There was previous temperature excursion above 47 degrees Fahrenheit (64.83 degrees Fahrenheit) for 13.35 hours. Data logger was involved. No additional adverse effect was reported.
This spontaneous report as received from a 78 year old female patient with diabetes refers to herself. In approximately 2012 (reported as "about 2 years ago"), the patient was vaccinated with a dose of ZOSTAVAX (route, lot#, dose and frequency unknown). Concomitant therapies included acetaminophen, TYLENOL PM, metformin and glipizide. On 18-DEC-2014 the patient experienced shingles, which was treated with Valacyclovir hydrochloride. She sought medical attention via office visit. The outcome of the shingles was reported as not recovered/not resolved. The relationship of the shingles and ZOSTAVAX was not reported. Additional information has been requested.
Vaccine from 2 vials which are moved from freezer to refrigerator 30 days ago are administered to 12 patients on 31st day; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine from 2 vials which are moved from freezer to refrigerator 30 days ago are administered to 12 patients on 31st day) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine from 2 vials which are moved from freezer to refrigerator 30 days ago are administered to 12 patients on 31st day). At the time of the report, PRODUCT STORAGE ERROR (Vaccine from 2 vials which are moved from freezer to refrigerator 30 days ago are administered to 12 patients on 31st day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications and treatment information were reported.
My husband received his Pfizer booster vaccine on Oct. 29, 2021.  Two weeks later I had to call 911.  My husband was staring with no eye movement.  He would not respond by talking to him or snapping fingers in front of his eyes.  It was like he wasn?t there.  His behavior was strange and I finally got him to a least to sit down. Then his lip started twitching and body had odd movements. He fell in the floor and his whole body started to convulse.  He was  unresponsive. Medics were close to  intubating him. He started to respond and was taken to the ER.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Oct2022 at 12:00 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 61 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Arteriosclerosis" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Thimerosal, reaction(s): "Allergy". Vaccination history included: Covid-19 vaccine (DOSE NUMBER 4 (BOOSTER), SINGLE, Brand: Unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE NUMBER 3 (BOOSTER), SINGLE, Brand: Unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE NUMBER 2, SINGLE, Brand: Unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE NUMBER 1, SINGLE, Brand: Unknown), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 15Oct2023 at 02:00, outcome "not recovered", COVID-19 (medically significant) with onset 15Oct2023 at 02:00, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Oct2023) positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: patient experienced full symptoms again of covid and tested positive again on rapid antigen test . Fever 101.5, headache, cough, chills myalgia. Symptoms are on day 5 and still fever and aches. taking tylenol. getting rest.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
ARM IS VERY SORE AND PATIENT HAS BEEN IN PAIN FOR TWO WEEKS SINCE SHE RECEIVED THE VACCINE. ARM IS ALSO VISIBLY BRUISED AROUND THE INJECTION SITE.
9/8/10 extreme soreness, knot, 1/2 inch diameter red mark; 9/10/10 1 inch separate red mark developed; fever/chills around 100 degrees F; whole body aches.
Headache daily in the morning. On 2/26/21 developed a migraine with vomiting and went to ER. Today on 3/1/21 continues to have headache every morning but not as severe and today has had 3 loose, watery stools.
Felt some palpitations, racing heart, scratchy throat, dizziness, a little shortness of breath. Alerted the professionals observing and was monitored. Starting feeling a little better, then got a second wave of above symptoms again. I felt tingly all over and my lips felt tingly. They ended up taking me to ER. I started to also feel nauseous. They ended up giving me 1L of fluid, 25mg of diphenhydramine, 125mg of solumedrol, and 20mg of Pepcid. Monitored me for a few hours and then discharged me home. I was instructed to take another 50mg of diphenhydramine before bed, which I did.  I ended up missing work the rest of my shift since I was in ER, then missed work the next day.
I am not Allergic to Pet Dander anymore. My reaction to Fiberglass Insulation now also about 10-20% with no severe redness or skin breakout. Also the the Calcium deposits I had on my left arm that made a very large Egg Shaped extrusion raising my skin as well as Calcium deposits on my my hands became less. I was looking with a Doctor for removal because the buildup had become large and was mecially stated it would probably get larger, but was not cancer or cause any health issues.  (This is the Patient that has entered everything on these documents)
4 days after the vaccine patient hands was swollen  tried to get rid of the inflammation with ibuprofen went to hospital on a street they provided patient with Prodizone reduced swelling in the left hand didn't really help the left hand. three days later went to his appointment right hand was still stiff and swollen . Went to other doctors but the right hand still hasn't recovered was told that he had damaged nerves. Right hand still hasn't recovered
Mid October he began complaining about random chest pains. He could be watching TV and have random chest pain. They lasted 30 seconds to a minute. After the pain would subside he would have difficulty breathing for another minute or two. This would occur 3-4 times a day for 2-3 weeks. Took him to a PCP in the same clinic. Was referred to cardiologist. Went to cardiologist in November and ran several tests. It was determined that there was a 1% leakage in one of his valves and that it was normal for children his age.
Rash on arms and chest with hives very itchy everywhere. Happened with first shot but not as bad and I thought it was something else until it happened again with second shot
About 5 minutes after the vaccination, my BP and HR shot up and my tongue felt swollen.  I felt really flushed and I was transferred to the ED where my vitals and lab were drawn.
On an unspecified date, the vaccinee received a dose of Infanrix; it was not known whether the vaccinee had received previous doses of Infanrix. Subsequently, the vaccinee experienced injection site edema and redness. As of 8/21/01, the outcome of the adverse events was unknown.
Took shot, got them anyway/Suspected vaccination failure; took the shot and got them anyway; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Took shot, got them anyway/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: took the shot and got them anyway). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.  It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional Information: GSK receipt date: 26-APR-2023 This case was reported by the patient via interactive digital media. The patient had stated that, he/she had not had the shot yet and would not get it too. Several of his/her friends took the shot and got those (Shingles) anyway. The reporter had asked why he/she would risk taking the shot. Thanks, but no thanks. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible, as no contact details were available.
Experienced the exact same thing (dementia episode) after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of DEMENTIA (Experienced the exact same thing (dementia episode) after the second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEMENTIA (Experienced the exact same thing (dementia episode) after the second dose) (seriousness criterion medically significant). At the time of the report, DEMENTIA (Experienced the exact same thing (dementia episode) after the last dose) outcome was unknown.            No concomitant and treatment medications reported.  Company comment: Based on the current available information, although the use of the product and the start date of the events were not stated, a causal relationship cannot be excluded..; Sender's Comments: Based on the current available information, although the use of the product and the start date of the events were not stated, a causal relationship cannot be excluded..